The short answer
Women living with HIV can usually use menopausal hormone therapy; HIV is not a contraindication. Transdermal estradiol is generally preferred. Most modern unboosted ART regimens have no meaningful interaction, while boosted protease inhibitors and efavirenz may need dose adjustment. Your HIV clinician keeps managing ART, and menopause care is coordinated only with your permission.
No advertising or analytics trackers run on Specialized Care pages. Reading them is never linked to your identity. Our privacy pledge
Why HIV changes menopause care
With effective treatment, many women living with HIV are now reaching midlife and beyond. Research from U.S. and UK cohorts suggests menopause may come somewhat earlier, symptoms may be more bothersome, and women are less often offered treatment. Bone loss and cardiovascular risk also run higher. None of this means care is harder to get right; it means clinicians should ask the right questions.
How Kindr clinicians approach care
- A full review of your ART regimen before anything is prescribed
- Transdermal estradiol as the usual first choice when hormone therapy is appropriate
- Non-hormonal options chosen with your regimen in mind
- Attention to bone density, lipids and blood pressure
- Coordination with your HIV clinician, only with your permission
Explore the complete HIV and menopause guides
| Guide | What it covers |
|---|---|
| Complete guide (/hiv-menopause) | Overview of timing, symptoms, treatment and care |
| Early menopause and HIV | Earlier onset, POI and when to get checked |
| Hormone therapy with HIV | Why HRT is not contraindicated; transdermal estradiol |
| Drug interactions | Which ART classes interact and how it is managed |
| Non-hormonal options | Veozah, Lynkuet, SNRIs, gabapentin |
| Bone and heart health | Higher risks and the screening that helps |
| Menopause vs HIV symptoms | Telling overlapping symptoms apart |
| What to expect at a visit | The process and how coordination works |
Your privacy
No advertising or analytics trackers run on these pages or on the preparation tool. The preparation tool works entirely in your browser; nothing you enter is saved or sent. Anything you choose to share later in a clinical intake is protected health information handled under HIPAA.
Specialized care pathway
Care that takes your history into account
A private preparation tool builds a summary for a licensed Kindr clinician. Your answers stay in your browser and are not saved or sent.
Questions, answered
Common questions
Is HRT safe if I am living with HIV?
+
HIV is not a contraindication to hormone therapy. Clinicians weigh the same factors as for anyone else, prefer transdermal estradiol, and check your ART regimen for interactions before prescribing.
Will I have to change my HIV medicines?
+
No. Menopause care is planned around your ART. Where an interaction exists, the hormone dose or type is adjusted, and any ART decision stays with your HIV clinician.
Do women with HIV go through menopause earlier?
+
Several studies suggest earlier average menopause, partly linked to smoking, low CD4 counts and social factors. Symptoms deserve evaluation regardless of age.
WRITTEN & MEDICALLY REVIEWED BY
Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team, led by Kevin Wolfe, CMO
Kindr’s clinical content is written and reviewed by board-certified clinicians who prescribe hormone therapy every day across all 50 states — menopause-focused physicians, nurse practitioners, and pharmacists working under Kindr Health, Inc.’s organizational clinical oversight. Every page is checked against current NAMS and ACOG guidance, FDA labeling, and the primary literature before publication, then re-reviewed on a rolling schedule when guidance changes.
Organizational NPI 1609792902 · Last reviewed October 5, 2026 · Editorial policy
Educational content only — not a substitute for individual medical advice, diagnosis, or treatment.
SOURCES & REFERENCES
Every clinical claim on this page is sourced.
- Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV: Women with HIV — DHHS, Clinicalinfo.HIV.gov. clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/women-hiv
- HIV Drug Interactions Checker — University of Liverpool. www.hiv-druginteractions.org/checker
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society (2022) — The Menopause Society. www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf
- The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society (2023) — Menopause (journal of The Menopause Society). pubmed.ncbi.nlm.nih.gov/?term=2023+nonhormone+therapy+position+statement+North+American+Menopause+Society